- Published at
- by themarketherald.com.au
mixed
mixed
ASX Market Close: BHP shares rise with iron ore – but so does CBA
Good Afternoon and welcome to HotCopper’s Market Close for Thursday 10th of July, I’m Jon Davidson. It was a green day at least...
News for Orthocell Limited (OCC.AX)
- Published at
- by smallcaps.com.au
positivepositiveOrthocell Posts Record Full-Year Revenue, Takes Remplir and Striate into New Global Markets
Regenerative medicine company Orthocell (ASX: OCC) has reported a record revenue of $9.19 million for the 12 months to the end of June 2025, underscoring- Published at
- by themarketherald.com.au
mixedmixedHotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin
Good Afternoon and welcome to HotCopper Highlights for the end of Week 26, I’m Jon Davidson. In this segment, the...- Published at
- by themarketherald.com.au
neutralneutralOrthocell sees 4% jump as Remplir used in first US surgery. But is that low?
Orthocell (ASX:OCC) shares notched upwards on Friday as the company announced its nerve repair product has been...- Published at
- by smallcaps.com.au
positivepositiveOrthocell’s Remplir nerve repair technology sees first surgical use in US procedure
Regenerative medicine company Orthocell (ASX: OCC) has achieved a major breakthrough in the global development of its Remplir technology with the- Published at
- by themarketherald.com.au
mixedmixedFriday’s HotCopper Trends: Orthocell ramps up, Australian Vanadium advances project | May 8, 2025
The ASX200 has been up 0.45% at around 8,230 points. Orthocell (ASX:OCC)…- Published at
- by themarketherald.com.au
mixedmixedASX Market Close: Index continues winning streak | April 30, 2025
The ASX200 closed up 0.69% at 8,126 points. IT was the best…- Published at
- by themarketherald.com.au
mixedmixed- Published at
- by smallcaps.com.au
positivepositiveOrthocell appoints first four distributors for Remplir nerve repair technology in the US
Regenerative medicine company Orthocell (ASX: OCC) has appointed the first four US distributors for the company’s flagship nerve repair product Remplir.- Published at
- by themarketherald.com.au
positivepositiveASX Market Close: Local bourse back to 7,800pts ahead of Easter long weekend
The ASX went its own way despite Wall Street’s overnight finish to close out this shortened trading week, climbing back above the 7,800 points level.- Published at
- by themarketherald.com.au
mixedmixedASX Market Close: Tariff pause bounceback lifts animal spirits, but certainty elusive
Good Afternoon and welcome to HotCopper’s Market Close for Thursday 10th of April,…- Published at
- by themarketherald.com.au
mixedmixedFriday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025
The ASX has been down 1.5% at 7,739 points this morning. There’s…- Published at
- by themarketherald.com.au
mixedmixedThursday’s HotCopper Trends: Ramelius’ record, Enova’s drill success | April 3, 2025
The ASX has pared losses and has been down 1.25% at 7,835…- Published at
- by smallcaps.com.au
positivepositiveOrthocell records first sales of Striate+ dental membrane in new European markets
Orthocell (ASX: OCC) has achieved the first sales of its dental guided bone and tissue regeneration product Striate+ into new markets in Germany, Austria- Published at
- by themarketherald.com.au
positivepositiveASX Market Close: Index pares gains, Gold hits new record | March18, 2025
The ASX200 pared early gains to close up by a sliver of…- Published at
- by smallcaps.com.au
positivepositiveOrthocell receives regulatory approval for sales of Striate+ dental membrane into Singapore
Orthocell (ASX: OCC) has received regulatory approval from Singapore’s Health Sciences Authority to commence regional sales of its dental membrane product- Published at
- by themarketherald.com.au
positivepositiveTelix clocks +150% year-on-year returns as radiopharma acquisition well received
Telix Pharmaceuticals (ASX:TLX) has joined a somewhat quiet cohort of ASX biotech companies having a pretty good run lately.- Published at
- by themarketherald.com.au
positivepositiveClarity jumps as FDA awards fast track status for PET scan imaging agent
Clarity Pharmaceuticals (ASX:CU6) has seen the U.S. FDA fast-track its prostate cancer…- Published at
- by themarketherald.com.au
mixedmixedASX Market Close: IT stocks lead index higher | January 22, 2025
This was a seven-week closing high, achieved amidst positive sentiment as investors react to Donald Trump’s “Stargate” plan for AI investment.- Published at
- by themarketherald.com.au
positivepositiveASX Market Update: Inflation higher than expected as miners bounce back | January 8, 2025
Inflation edged up more than expected, from 2.1% to 2.3%. More importantly, trimmed mean inflation came in at 3.2%.